Experimental Biology and Medicine · 1960 · 20 citations · 0 references
Life SciencesEndocrinologyVeterinary PharmacologyPharmacodynamicsCholestatic Liver InjuryCholesterol MetabolismLipid MetabolismLipid Metabolism DisordersLipid-lowering TherapyLiver DiseaseCholesterol AccumulationFatty InfiltrationHigh-density Lipoprotein MetabolismInfiltrationPlasma Cholesterol Levels
Summaryβ-Diethylaminoethyl diphenylpropylacetate hydrochloride (SKF No. 525-A) reduced significantly plasma total cholesterol and aortic cholesterol in dogs. Chronic daily administration of the SKF No. 525-A to dogs for 5 months resulted in marked fatty infiltration of the liver, which was rapidly reversible upon withdrawal of the compound.